These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 21539754)

  • 1. The novel roles of four and a half LIM proteins 1 and 2 in the cardiovascular system.
    Chu PH; Chen J
    Chang Gung Med J; 2011; 34(2):127-34. PubMed ID: 21539754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A review of the research progress on LIM protein family].
    Zheng B; Wen JK; Han M
    Sheng Li Ke Xue Jin Zhan; 2002 Oct; 33(4):305-8. PubMed ID: 12650064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human four-and-a-half LIM family members suppress tumor cell growth through a TGF-beta-like signaling pathway.
    Ding L; Wang Z; Yan J; Yang X; Liu A; Qiu W; Zhu J; Han J; Zhang H; Lin J; Cheng L; Qin X; Niu C; Yuan B; Wang X; Zhu C; Zhou Y; Li J; Song H; Huang C; Ye Q
    J Clin Invest; 2009 Feb; 119(2):349-61. PubMed ID: 19139564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mapping of FHL2 transcription activation domain].
    Yan JH; Ye QN; Fang Y; Zhu JH; Huang CF
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Jul; 35(7):643-8. PubMed ID: 12883635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FHL family members suppress vascular endothelial growth factor expression through blockade of dimerization of HIF1α and HIF1β.
    Lin J; Qin X; Zhu Z; Mu J; Zhu L; Wu K; Jiao H; Xu X; Ye Q
    IUBMB Life; 2012 Nov; 64(11):921-30. PubMed ID: 23086815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The biological relevance of FHL2 in tumour cells and its role as a putative cancer target.
    Kleiber K; Strebhardt K; Martin BT
    Anticancer Res; 2007; 27(1A):55-61. PubMed ID: 17352216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Four-and-a-half LIM protein 2 promotes invasive potential and epithelial-mesenchymal transition in colon cancer.
    Zhang W; Jiang B; Guo Z; Sardet C; Zou B; Lam CS; Li J; He M; Lan HY; Pang R; Hung IF; Tan VP; Wang J; Wong BC
    Carcinogenesis; 2010 Jul; 31(7):1220-9. PubMed ID: 20460358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein-protein interaction of FHL3 with FHL2 and visualization of their interaction by green fluorescent proteins (GFP) two-fusion fluorescence resonance energy transfer (FRET).
    Li HY; Ng EK; Lee SM; Kotaka M; Tsui SK; Lee CY; Fung KP; Waye MM
    J Cell Biochem; 2001; 80(3):293-303. PubMed ID: 11135358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein-protein interactions of the LIM-only protein FHL2 and functional implication of the interactions relevant in cardiovascular disease.
    Tran MK; Kurakula K; Koenis DS; de Vries CJ
    Biochim Biophys Acta; 2016 Feb; 1863(2):219-28. PubMed ID: 26548523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Four-and-a-half LIM domain protein 2 is a novel regulator of sphingosine 1-phosphate receptor 1 in CCL19-induced dendritic cell migration.
    König K; Diehl L; Rommerscheidt-Fuss U; Golletz C; Quast T; Kahl P; Kolanus W; Knolle P; Buettner R; Heukamp LC
    J Immunol; 2010 Aug; 185(3):1466-75. PubMed ID: 20592280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The LIM-only proteins FHL2 and FHL3 interact with alpha- and beta-subunits of the muscle alpha7beta1 integrin receptor.
    Samson T; Smyth N; Janetzky S; Wendler O; Müller JM; Schüle R; von der Mark H; von der Mark K; Wixler V
    J Biol Chem; 2004 Jul; 279(27):28641-52. PubMed ID: 15117962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FHL2/SLIM3 decreases cardiomyocyte survival by inhibitory interaction with sphingosine kinase-1.
    Sun J; Yan G; Ren A; You B; Liao JK
    Circ Res; 2006 Sep; 99(5):468-76. PubMed ID: 16888242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disruption of four-and-a-half LIM 2 decreases bone mineral content and bone mineral density in femur and tibia bones of female mice.
    Govoni KE; Baylink DJ; Chen J; Mohan S
    Calcif Tissue Int; 2006 Aug; 79(2):112-7. PubMed ID: 16927043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Four-and-a-half LIM domains proteins are novel regulators of the protein kinase D pathway in cardiac myocytes.
    Stathopoulou K; Cuello F; Candasamy AJ; Kemp EM; Ehler E; Haworth RS; Avkiran M
    Biochem J; 2014 Feb; 457(3):451-61. PubMed ID: 24219103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FHL2 (SLIM3) is not essential for cardiac development and function.
    Chu PH; Bardwell WM; Gu Y; Ross J; Chen J
    Mol Cell Biol; 2000 Oct; 20(20):7460-2. PubMed ID: 11003643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The LIM proteins FHL1 and FHL3 are expressed differently in skeletal muscle.
    Morgan MJ; Madgwick AJ
    Biochem Biophys Res Commun; 1999 Feb; 255(2):245-50. PubMed ID: 10049693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The roles of FHL2 in cancer.
    Zhang J; Zeng Q; She M
    Clin Exp Med; 2023 Nov; 23(7):3113-3124. PubMed ID: 37103649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Four and a half LIM domains protein 1 can be as a double-edged sword in cancer progression.
    Wei X; Zhang H
    Cancer Biol Med; 2020 May; 17(2):270-281. PubMed ID: 32587768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Four and a half LIM domains 1 (FHL1) and receptor interacting protein of 140kDa (RIP140) interact and cooperate in estrogen signaling.
    Lin J; Ding L; Jin R; Zhang H; Cheng L; Qin X; Chai J; Ye Q
    Int J Biochem Cell Biol; 2009 Jul; 41(7):1613-8. PubMed ID: 19401155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of the heart-specific LIM domain protein, FHL2, with DNA-binding nuclear protein, hNP220.
    Ng EK; Chan KK; Wong CH; Tsui SK; Ngai SM; Lee SM; Kotaka M; Lee CY; Waye MM; Fung KP
    J Cell Biochem; 2002; 84(3):556-66. PubMed ID: 11813260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.